Klingenstein Fields & Co’s ContraFect Corporation CFRX Stock Holding History

Klingenstein Fields & Co’s Portfolio CFRX Stock Details CFRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-19	Closed	-$9K	–	193
2019 Q4	$9K	Hold	19	–	–	﹤0.01%	187
2019 Q3	$5K	Hold	19	–	–	﹤0.01%	188
2019 Q2	$8K	Hold	19	–	–	﹤0.01%	190
2019 Q1	$6K	Hold	19	–	–	﹤0.01%	190
2018 Q4	$23K	Hold	19	–	–	﹤0.01%	192
2018 Q3	$31K	Hold	19	–	–	﹤0.01%	212
2018 Q2	$33K	Hold	19	–	–	﹤0.01%	210
2018 Q1	$24K	Hold	19	–	–	﹤0.01%	218
2017 Q4	$15K	Hold	19	–	–	﹤0.01%	223
2017 Q3	$17K	Hold	19	–	–	﹤0.01%	217
2017 Q2	$22K	Hold	19	–	–	﹤0.01%	221
2017 Q1	$27K	Hold	19	–	–	﹤0.01%	225
2016 Q4	$26K	Hold	19	–	–	﹤0.01%	227
2016 Q3	$37K	Hold	19	–	–	﹤0.01%	223
2016 Q2	$43K	Hold	19	–	–	﹤0.01%	211
2016 Q1	$51K	Hold	19	–	–	﹤0.01%	212
2015 Q4	$71K	Hold	19	–	–	﹤0.01%	214
2015 Q3	$67K	Buy	+19	New	+$74.9K	﹤0.01%	228

Other funds holding CFRX

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

WPC

White Pine Capital Bloomington, Minnesota $355M AUM 45.63% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Klingenstein Fields & Co's CFRX Position: Q1 2020 in Review

Klingenstein Fields & Co sold out of ContraFect Corporation (CFRX) in Q1 2020, closing a stake of 19 shares — an estimated $9K sold.

Klingenstein Fields & Co first reported a position in CFRX in Q3 2015 and held it in 18 quarters. The position peaked at $71K in Q4 2015. 29 funds tracked by Wall St. Rank hold CFRX as of Q1 2020.

Klingenstein Fields & Co reported no remaining ContraFect Corporation position as of Q1 2020 after selling out during the quarter.
Klingenstein Fields & Co sold 19 ContraFect Corporation shares in Q1 2020, an estimated $9K.
Klingenstein Fields & Co first reported a position in ContraFect Corporation in Q3 2015 and held it in 18 quarters.
Klingenstein Fields & Co's ContraFect Corporation position peaked at $71K in Q4 2015.
29 funds tracked by Wall St. Rank held ContraFect Corporation as of Q1 2020.

Based on Klingenstein Fields & Co's 13F filing for Q1 2020, filed 7 May 2020.